Home » Symbollon Files New Patent Application Covering the Chronic Administration of IoGen to Women
Symbollon Files New Patent Application Covering the Chronic Administration of IoGen to Women
Symbollon Pharmaceuticals, Inc. announced that the company has filed a new patent application covering IoGen, its proprietary compound being evaluated for its ability to eliminate excess tissue growth in female reproductive organs.
Yahoo Finance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May